Viewing Study NCT02645305


Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-03-01 @ 6:11 AM
Study NCT ID: NCT02645305
Status: UNKNOWN
Last Update Posted: 2016-01-01
First Post: 2015-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease
Sponsor: University of Science Ho Chi Minh City
Organization:

Study Overview

Official Title: Evaluation of Safety and Efficacy of Autologous Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease
Status: UNKNOWN
Status Verified Date: 2015-12
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Chronic obstructive pulmonary disease (COPD) is the name for a collection of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways disease. People with COPD have difficulties breathing, primarily due to the narrowing of their airways, this is called airflow obstruction.

Some preclinical evaluations showed that COPD is closely related to chronic inflammation; therefore, this study aimed to use adipose-derived stem cells (ADSCs) in the form of non-expanded culture - that usually names as a stromal vascular fraction (SVF) in combination with activated platelet rich plasma (PRP) to treat this disease. Both SVF and PRP are autologous sources that obtained from adipose tissue and peripheral blood, respectively. This mixture is intravenously transfused into the patients.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: